Table V.
Crude OR (95% CI) | Adjusted OR (95% CI)a | Adjusted OR (95% CI)b | |
HOMA score | |||
<4 | 1 | 1 | 1 |
≥4 | 2.13 (1.26–3.60) | 1.95 (1.07–3.56) | 1.80 (0.97–3.31) |
Clinical lipodystrophy | 1.12 (0.72–1.74) | 0.86 (0.51–1.46) | 1.12 (0.64–1.96) |
Lipodystrophy defined by FMR | 1.51 (0.87–2.62) | 0.95 (0.46–1.94) | 0.97 (0.47–2.01) |
Body fat mass by quantitative CT | |||
Total fat, mean (SD), cm2 | 1.00 (1.00–1.01) | 1.00 (1.00–1.01) | 1.00 (0.99–1.00) |
Central fat, mean (SD), cm2 | 1.01 (1.01–1.01) | 1.01 (1.00–1.01) | 1.00 (0.99–1.00) |
Peripheral fat, mean (SD), cm2 | 1.00 (1.00–1.01) | 1.00 (1.00–1.01) | 1.00 (0.99–1.00) |
Central/peripheral ratio, mean (SD) | 1.27 (1.06–1.52) | 1.15 (0.94–1.40) | 1.26 (1.01–1.57) |
DXA | |||
Total body fat mass, % | 1.03 (1.00–1.05) | 1.05 (1.01–1.09) | 1.02 (0.96–1.08) |
Leg body fat mass, % | 1.01 (0.99–1.03) | 1.02 (0.99–1.05) | 1.00 (0.96–1.04) |
Arm body fat mass, % | 1.01 (0.98–1.02) | 1.04 (1.01–1.08) | 1.03 (0.98–1.07) |
Trunk body fat mass, % | 1.04 (1.10–2.00) | 1.04 (1.01–1.08) | 1.01 (0.96–1.07) |
FMR by DXA, mean (SD) | 1.48 (1.10–2.00) | 1.17 (0.79–1.74) | 1.16 (0.78–1.73) |
Abbreviations: CI, confidence interval; CT, computed tomography; DXA, dual‐energy x‐ray absorptiometry; FMR, fat mass ratio; HOMA, Homeostatic Model Assessment; SD, standard deviation. aOdds ratio (OR) adjusted for age, sex, and smoking history. bOR adjusted for age, sex, smoking history and body mass index (BMI).